News & Analysis on Clinical Trial Services & Contract Research And Development
Chemists at MIT have created a triple warhead against cancer. They believe theirs is the first example a polymer nanoparticle which carries a precise ratio of three drugs that can be released in response to three distinct triggers.
Wuxi PharmaTech has completed an expansion of its materials characterization testing facility in St. Paul, Minnesota, as well as its work on a new biologics biosafety testing facility in Suzhou, China.
For the first time ever, Charles River Laboratories is seeing its biotech revenues eclipse its pharma revenues, Jim Foster, chairman, president and CEO of CRL, told participants at the Baird Growth Stock Conference last week.
Experiments on semiconductors reveal a new way to study and control crystallisation. The discovery has relevance to pharmaceutical manufacturing as many drugs are made from small molecules that must crystallise in just the right way to have the proper...
Evotec revenues rose slightly by 3% for the first three months of 2014, when compared with the same quarter in 2013.
As the worldwide pharma supply chain gets even more complex, the US FDA is looking to leverage its existing relationship with its EMA (European Medicines Agency) counterparts to boost drug quality with a new initiative.